Related Experiment Video

Updated: May 4, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.3K

Systematic identification of genomic markers of drug sensitivity in cancer cells

Mathew J Garnett1, Elena J Edelman, Sonja J Heidorn

  • 1Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.

Nature
|March 31, 2012
PubMed

Insights

Identifying new cancer biomarkers is crucial. This study screened hundreds of cancer cell lines with 130 drugs, revealing mutated genes as key indicators of drug sensitivity and resistance for targeted cancer therapies.

Area of Science:

  • Oncology
  • Genomics
  • Pharmacology

Background:

  • Clinical responses to cancer treatments vary significantly among patients.
  • Mutated cancer genes can serve as predictive biomarkers for targeted therapies.
  • Discovering novel biomarkers is essential for improving cancer treatment efficacy.

Purpose of the Study:

  • To identify new biomarkers for sensitivity and resistance to cancer therapeutics.
  • To systematically profile pharmacogenomic relationships in diverse cancer cell lines.

Main Methods:

  • Screening of several hundred cancer cell lines representing diverse cancer types and genetic profiles.
  • Testing the efficacy of 130 drugs (clinical and preclinical) against these cell lines.
  • Analyzing associations between mutated cancer genes and cellular drug responses.

Main Results:

  • Mutated cancer genes were broadly associated with cellular responses to most cancer drugs.
  • Tissue-specific or expression biomarkers modified classic oncogene addiction models.
  • A novel association was found between EWS-FLI1 translocation in Ewing's sarcoma and sensitivity to PARP inhibitors.

Conclusions:

  • Systematic pharmacogenomic profiling in cell lines is a powerful platform for biomarker discovery.
  • Linking drug activity to cancer genome complexity aids in guiding rational therapeutic strategies.
  • The findings expand the understanding of genetic biomarkers for predicting cancer drug response.

More Related Videos

Assessing Specificity of Anticancer Drugs In Vitro09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

13.3K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

6.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121